Medication info
BeaRotan Tablet 50 mg (Losartan Potassium)

BeaRotan Tablet 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201603009 · Approved 2016.05.30 · Insurance code 694001160

Summary

Main use
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided into 2 daily doses for oral administration, or the dose may be increased to 100 mg once daily if needed. If blood pressure is not controlled with this medicine alone, it may be used in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Older adults: No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For those over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment: Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment: Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced effective intravascular volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients being treated with diuretics) (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this medicine once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to effectively control blood pressure in patients with hypertension. In particular, it is helpful in the treatment of kidney disease related to hypertension in patients with type 2 diabetes. It helps to prevent kidney damage and stabilizes blood pressure, thus improving overall health. It can be used safely for managing complications in patients with hypertension and diabetes.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided into 2 daily doses for oral administration, or the dose may be increased to 100 mg once daily if needed. If blood pressure is not controlled with this medicine alone, it may be used in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Older adults: No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For those over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment: Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment: Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced effective intravascular volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients being treated with diuretics) (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this medicine once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during the second and third trimesters of pregnancy, so women who are pregnant or may become pregnant should not take it. If pregnancy is confirmed, this medication should be stopped immediately, and regular testing should be done to check the fetus's health. This medication should not be given to patients with severely impaired liver function or specific genetic diseases, and care should be taken in patients with a history of angioedema. Additionally, patients with diabetes or moderate to severe kidney dysfunction should avoid combination therapy with certain medications. Caution should be exercised when administering this medication to elderly patients, patients with high serum potassium levels, or those with slightly impaired liver function, as well as in patients with heart valve diseases or those at risk of rapid drops in blood pressure. This medication has a blood pressure-lowering effect, and dizziness or fainting may occur when first taking it or increasing the dosage, so if such symptoms occur, stop taking it immediately and consult a doctor. Regular checks of blood pressure, kidney function, and electrolyte levels should be performed during treatment to detect any abnormalities, especially to prevent hyperkalemia. This medication may increase potassium levels in the blood, so it is advisable not to take it with potassium supplements or medications containing potassium. Furthermore, avoid grapefruit juice while taking this medication, and if taking other medications, consult a doctor or pharmacist about possible interactions. This medication is not recommended for nursing mothers, and if necessary to take, breastfeeding should be discontinued. Children, especially those under 6 years old or with very impaired kidney function, should not use this medication. Overdose may lead to hypotension and rapid heartbeat, requiring immediate medical attention. Store out of reach of children and avoid transferring to other containers.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • muscle cramps
  • back pain
  • leg pain
  • dizziness
  • congestion
  • upper respiratory tract infection
Show 125 more
  • sinusitis
  • nausea
  • diarrhea
  • indigestion
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • bloating
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm desquamation
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatus
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decrease
  • decreased libido
  • memory disturbance
  • migraine
  • nervousness
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photodermatosis
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning
  • eye pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision impairment
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • dry cough
  • soft tissue infection
  • vascular edema
  • vasculitis
  • anaphylactic-like syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • increased creatine kinase
  • rhabdomyolysis
  • acute renal failure
  • erythema multiforme
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • hypoglycemia
  • weight gain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so keep it in a tightly sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius. This will help preserve the medication's effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.